Skip to main content
Clinical Trials/NCT01403467
NCT01403467
Completed
Phase 4

Impact of Continuous Positive Airway Pressure on the Treatment of Acute Asthma Exacerbation

Ramathibodi Hospital1 site in 1 country86 target enrollmentApril 2009
ConditionsAcute Asthma

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Acute Asthma
Sponsor
Ramathibodi Hospital
Enrollment
86
Locations
1
Primary Endpoint
an improvement in PEFR, as % predicted
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

This current study aimed to demonstrate the effectiveness of the addition of CPAP to the current conventional therapy in terms of airway obstruction improvement in acute asthma patients.

Detailed Description

Continuous positive airway pressure (CPAP) is widely used in providing ventilator support. However, its role in an acute asthmatic attack is uncertain. The purpose of this study was to compare the efficacy of CPAP when used in addition to conventional therapy with conventional therapy alone in the management of acute asthma exacerbation.

Registry
clinicaltrials.gov
Start Date
April 2009
End Date
January 2011
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • aged over 18 years
  • known asthmatic patients visiting ED with acute exacerbation
  • had given their written informed consent.

Exclusion Criteria

  • smoking history
  • chronic obstructive pulmonary disease
  • required intubation
  • instability of hemodynamic or arrhythmia
  • unable to perform PEFR
  • facial abnormality
  • pulmonary infiltration
  • pregnancy.

Outcomes

Primary Outcomes

an improvement in PEFR, as % predicted

Time Frame: 75 mins

Study Sites (1)

Loading locations...

Similar Trials